http://jnci.oxfordjournals.org/content/102/24/1845.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
         
      </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/102/24/1845" />
      <meta content="/jnci/102/24/1845.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials"
            name="DC.Title" />
      <meta content="10.1093/jnci/djq409" name="DC.Identifier" />
      <meta content="2010-12-15" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Luisa Bonilla" name="DC.Contributor" />
      <meta content="Irit Ben-Aharon" name="DC.Contributor" />
      <meta content="Liat Vidal" name="DC.Contributor" />
      <meta content="Anat Gafter-Gvili" name="DC.Contributor" />
      <meta content="Leonard Leibovici" name="DC.Contributor" />
      <meta content="Salomon M. Stemmer" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Luisa Bonilla" />
      <meta name="citation_author_institution"
            content="Affiliations of authors: Institute of Oncology (LB, IB-A, SMS) and Institute of Hematology (LV, AG-G), Davidoff Center, Rabin Medical Center and Department of Medicine E, Rabin Medical Center (LL), Beilinson Campus, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (IBA, LV, AG-G, LL, SMS)" />
      <meta name="citation_author" content="Irit Ben-Aharon" />
      <meta name="citation_author_institution"
            content="Affiliations of authors: Institute of Oncology (LB, IB-A, SMS) and Institute of Hematology (LV, AG-G), Davidoff Center, Rabin Medical Center and Department of Medicine E, Rabin Medical Center (LL), Beilinson Campus, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (IBA, LV, AG-G, LL, SMS)" />
      <meta name="citation_author" content="Liat Vidal" />
      <meta name="citation_author_institution"
            content="Affiliations of authors: Institute of Oncology (LB, IB-A, SMS) and Institute of Hematology (LV, AG-G), Davidoff Center, Rabin Medical Center and Department of Medicine E, Rabin Medical Center (LL), Beilinson Campus, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (IBA, LV, AG-G, LL, SMS)" />
      <meta name="citation_author" content="Anat Gafter-Gvili" />
      <meta name="citation_author_institution"
            content="Affiliations of authors: Institute of Oncology (LB, IB-A, SMS) and Institute of Hematology (LV, AG-G), Davidoff Center, Rabin Medical Center and Department of Medicine E, Rabin Medical Center (LL), Beilinson Campus, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (IBA, LV, AG-G, LL, SMS)" />
      <meta name="citation_author" content="Leonard Leibovici" />
      <meta name="citation_author_institution"
            content="Affiliations of authors: Institute of Oncology (LB, IB-A, SMS) and Institute of Hematology (LV, AG-G), Davidoff Center, Rabin Medical Center and Department of Medicine E, Rabin Medical Center (LL), Beilinson Campus, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (IBA, LV, AG-G, LL, SMS)" />
      <meta name="citation_author" content="Salomon M. Stemmer" />
      <meta name="citation_author_institution"
            content="Affiliations of authors: Institute of Oncology (LB, IB-A, SMS) and Institute of Hematology (LV, AG-G), Davidoff Center, Rabin Medical Center and Department of Medicine E, Rabin Medical Center (LL), Beilinson Campus, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel (IBA, LV, AG-G, LL, SMS)" />
      <meta content="Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials"
            name="citation_title" />
      <meta content="12/15/2010" name="citation_date" />
      <meta content="102" name="citation_volume" />
      <meta content="24" name="citation_issue" />
      <meta content="1845" name="citation_firstpage" />
      <meta content="1854" name="citation_lastpage" />
      <meta content="102/24/1845" name="citation_id" />
      <meta content="102/24/1845" name="citation_id_from_sass_path" />
      <meta content="jnci;102/24/1845" name="citation_mjid" />
      <meta content="10.1093/jnci/djq409" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/102/24/1845.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/102/24/1845.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/102/24/1845.full.pdf"
            name="citation_pdf_url" />
      <meta content="/content/102/24.cover.gif" name="issue_cover_image" />
      <meta content="http://jnci.oxfordjournals.org/content/102/24/1845"
            name="citation_public_url" />
      <meta content="21098761" name="citation_pmid" />
      <meta name="citation_fulltext_world_readable" content="" />
      <meta name="citation_section" content="Article" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/102/24/1835.short" rel="prev" />
      <link href="/content/102/24/1855.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d392270280e1">var callbackToken='537859EF1CA00AB';</script><script type="text/javascript" id="session-d392270280e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:13:33.209-07:00';
            var gSessionId = '2UknHcG0K51UAZ0LkSpQEQ';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip ip';
            var gAuthnMethods2 = 'ip,ip';
            var gAuthnIPs = '18.189.59.169,18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/djq409");
	    var siqIsOpenAccess = encodeURIComponent("");
	    var siqPubDate = encodeURIComponent("20101215");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F102%2F24%2F1845.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/102/24.toc">
                  <span xmlns="" class="volume-value">Volume 102</span>
                  <span xmlns="" class="issue-value"> Issue 24</span></a></li>
            <li>Pp. <span class="slug-pages">
                  1845-1854.
                  </span></li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/102/24/1845.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view " itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Luisa+Bonilla&amp;sortspec=date&amp;submit=Submit">Luisa Bonilla</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Irit+Ben-Aharon&amp;sortspec=date&amp;submit=Submit">Irit Ben-Aharon</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Liat+Vidal&amp;sortspec=date&amp;submit=Submit">Liat Vidal</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Anat+Gafter-Gvili&amp;sortspec=date&amp;submit=Submit">Anat Gafter-Gvili</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-5" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Leonard+Leibovici&amp;sortspec=date&amp;submit=Submit">Leonard Leibovici</a></span> and 
                     </li>
                     <li class="last" id="contrib-6"><span class="name"><a class="name-search"
                              href="/search?author1=Salomon+M.+Stemmer&amp;sortspec=date&amp;submit=Submit">Salomon M. Stemmer</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address><strong>Affiliations of authors:</strong> Institute of Oncology (LB, IB-A, SMS) and Institute of Hematology (LV, AG-G), Davidoff Center, Rabin Medical Center and Department
                           of Medicine E, Rabin Medical Center (LL), Beilinson Campus, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University,
                           Tel-Aviv, Israel (IBA, LV, AG-G, LL, SMS)
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1"><strong>Correspondence to:</strong><br /> Salomon M. Stemmer, MD, Institute of Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel (e-mail: <span class="em-link"><span class="em-addr">shtemers{at}clalit.org.il</span></span>).
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="2010-04-11"><span class="received-label">Received </span>April 11, 2010.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="2010-09-03"><span class="rev-recd-label">Revision received </span>September 3, 2010.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="2010-09-17"><span class="accepted-label">Accepted </span>September 17, 2010.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-11" title="Methods" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  <div id="sec-1" class="subsection">
                     <p id="p-2"><strong>Background</strong> Dose-dense chemotherapy has become a mainstay regimen in the adjuvant setting for women with high-risk breast cancer. We
                        performed a systematic review and meta-analysis of the existing data from randomized controlled trials regarding the efficacy
                        and toxicity of the dose-dense chemotherapy approach in nonmetastatic breast cancer.
                     </p>
                  </div>
                  <div id="sec-2" class="subsection">
                     <p id="p-3"><strong>Methods</strong> Randomized controlled trials that compared a dose-dense chemotherapy protocol with a standard chemotherapy schedule in the
                        neoadjuvant or adjuvant setting in adult women older than 18 years with breast cancer were identified by searching The Cochrane
                        Cancer Network register of trials, The Cochrane Library, and LILACS and MEDLINE databases (from January 1966 to January 2010).
                        Hazard ratios (HRs) of death and recurrence and relative risks of adverse events were estimated and pooled. All statistical
                        tests were two-sided.
                     </p>
                  </div>
                  <div id="sec-3" class="subsection">
                     <p id="p-4"><strong>Results</strong> Ten trials met the inclusion criteria and were classified into two categories based on trial methodology. Three trials enrolling
                        3337 patients compared dose-dense chemotherapy with a conventional chemotherapy schedule (similar agents). Patients who received
                        dose-dense chemotherapy had better overall survival (HR of death = 0.84, 95% confidence interval [CI] = 0.72 to 0.98, <em>P</em> = .03) and better disease-free survival (HR of recurrence or death = 0.83, 95% CI = 0.73 to 0.94, <em>P</em> = .005) than those on the conventional schedule. No benefit was observed in patients with hormone receptor–positive tumors.
                        Seven trials enrolling 8652 patients compared dose-dense chemotherapy with regimens that use standard intervals but with different
                        agents and/or dosages in the treatment arms. Similar results were obtained for these trials with respect to overall survival
                        (HR of death = 0.85, 95% CI = 0.75 to 0.96, <em>P</em> = .01) and disease-free survival (HR of recurrence or death = 0.81, 95% CI = 0.73 to 0.88, <em>P</em> &lt; .001). The rate of nonhematological adverse events was higher in the dose-dense chemotherapy arms than in the conventional
                        chemotherapy arms.
                     </p>
                  </div>
                  <div id="sec-4" class="subsection">
                     <p id="p-5"><strong>Conclusion</strong> Dose-dense chemotherapy results in better overall and disease-free survival, particularly in women with hormone receptor–negative
                        breast cancer. However, additional data from randomized controlled trials are needed before dose-dense chemotherapy can be
                        considered as the standard of care.
                     </p>
                  </div>
               </div>
               <p id="p-6">
                  <div class="boxed-text" id="boxed-text-1">
                     <div id="sec-5" class="subsection">
                        <h4>CONTEXT AND CAVEATS</h4>
                        <div id="sec-6" class="subsection">
                           <h5>Prior knowledge</h5>
                           <p id="p-7">Dose-dense chemotherapy has become a mainstay regimen in the adjuvant setting for women with high-risk breast cancer.</p>
                        </div>
                        <div id="sec-7" class="subsection">
                           <h5>Study design</h5>
                           <p id="p-8">Systematic review and meta-analysis of 10 randomized controlled trials that compared dose-dense chemotherapy with a standard
                              chemotherapy schedule in women with nonmetastatic breast cancer.
                           </p>
                        </div>
                        <div id="sec-8" class="subsection">
                           <h5>Contribution</h5>
                           <p id="p-9">Dose-dense chemotherapy results in better overall and disease-free survival, particularly in women with hormone receptor–negative
                              breast cancer. The rate of nonhematological adverse events was higher in the dose-dense chemotherapy arms than in the conventional
                              chemotherapy arms.
                           </p>
                        </div>
                        <div id="sec-9" class="subsection">
                           <h5>Implications</h5>
                           <p id="p-10">The lack of obvious benefit in patients with hormone receptor–positive breast cancer indicates the need for further prospective
                              randomized trials of the classical conserved design in this patient population.
                           </p>
                        </div>
                        <div id="sec-10" class="subsection">
                           <h5>Limitations</h5>
                           <p id="p-11">There was substantial statistical heterogeneity among the trials. The small number of included trials makes the outcomes more
                              likely to have been influenced by a potential publication bias.
                           </p>
                           <p id="p-12"><em>From the Editors</em></p>
                        </div>
                     </div>
                  </div>
               </p>
               <p id="p-13">The implementation of adjuvant therapy, hormonal therapy, and chemotherapy has made a major impact on disease-free survival
                  and overall survival in premenopausal and postmenopausal women with early-stage breast cancer (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>). Unfortunately, many breast cancer patients who are diagnosed and treated properly will suffer from recurrence and ultimately
                  die of this disease. Since the introduction of anthracycline-based regimens for the treatment of breast cancer and the demonstration
                  of their superiority to other combination chemotherapy (<a id="xref-ref-1-2" class="xref-bibr" href="#ref-1">1</a>), a variety of approaches have evolved regarding adjuvant polychemotherapy, including the addition of novel drugs such as
                  taxanes and targeted agents and the establishment of dose-intensive (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>) and dose-dense chemotherapy regimens (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>,<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>) that were based on mathematical models of human breast cancer growth (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>).
               </p>
               <p id="p-14">Administration of dose-dense chemotherapy became possible with the introduction of granulocyte colony-stimulating factor,
                  which allowed the chemotherapy courses to be condensed without causing unacceptable toxicity. A dose-dense chemotherapy approach
                  using concurrent doxorubicin and cyclophosphamide followed by paclitaxel was assessed in the pivotal Cancer and Leukemia Group
                  B 9741 trial, a phase III prospective randomized trial of adjuvant treatment of women with node-positive early-stage breast
                  cancer (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>). This trial showed a statistically significant improvement in disease-free survival and overall survival for the dose-dense
                  chemotherapy arm and has become the cornerstone for the current therapeutic treatment of early-stage breast cancer in many
                  centers.
               </p>
               <p id="p-15">The Italian Gruppo Oncologico Nord Ovest-Mammella InterGruppo trial used a similar approach to test a non-taxane–based regimen
                  (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>). Although the point estimates for event-free survival and overall survival favored the dose-dense regimen, they were not
                  statistically significant (<a id="xref-ref-7-2" class="xref-bibr" href="#ref-7">7</a>). A third trial in the neoadjuvant setting failed to show statistically significant improvement in pathological response
                  rates, disease-free survival, or overall survival for the dose-dense regimen (<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>). Several other randomized trials have examined the concept of dose-dense chemotherapy (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>–<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>); however, these studies are difficult to interpret because the treatment groups differed in terms of dose density, drug
                  regimens, number of cycles, and the application of sequential strategies.
               </p>
               <p id="p-16">Given this paucity of data, we performed a systematic review and meta-analysis of the evidence from randomized trials for
                  the efficacy and toxicity of the dose-dense chemotherapy approach in the treatment of early-stage and locally advanced breast
                  cancer.
               </p>
               <div class="section methods" id="sec-11">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-17" title="Results" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Methods</h2>
                  <div id="sec-12" class="subsection">
                     <h3>Search Strategy</h3>
                     <p id="p-17">Relevant randomized clinical trials were identified by searching the most recent update of The Cochrane Central Register of
                        Controlled Trials (January 2010), The Cochrane Library (January 2010 issue), and LILACS (Latin American and Caribbean Health
                        Sciences) and MEDLINE databases (January 1, 1966, to January 1, 2010). The terms “adjuvant,” “neoadjuvant,” and “dose-dense
                        chemotherapy” (and similar terms) and “breast cancer” and similar terms were cross-searched by using the following search
                        algorithm: ((dose-dense chemotherapy OR dense OR acceler* OR weekly OR bi-weekly OR biweekly) AND (Breast neoplasm MeSH OR
                        ((breast OR mammary OR mamario OR seno) AND (carcinoma OR malignan* OR neoplasm OR tumor)))) AND (randomized controlled trial
                        [pt]OR controlled clinical trial [pt]OR randomized controlled trial [mh]OR double-blind method [mh] OR single-blind method
                        [mh] OR clinical trial [pt] OR clinical trials [mh] OR (“clinical trial”) [tw] OR singl* [tw] OR doubl* [tw] OR trebl* [tw]
                        OR tripl* [tw] AND (mask* [tw] OR blind* [tw]))) OR (placebos [mh] OR placebo* [tw] or random* [tw] PR research design [mh:noexp]
                        OR comparative study [mh] OR evaluation studies [mh] OR follow up studies [mh] OR prospective studies [mh] OR control* [tw]
                        OR prospective* [tw] OR volunteer* [tw] NOT (animals [mh] NOT humans [mh]). We also searched for relevant abstracts in the
                        annual conference proceedings up to December 2009 for the American Society of Clinical Oncology, European Society for Medical
                        Oncology, and the San Antonio Breast Cancer Symposium. References of selected articles were scanned for any other relevant
                        trials, and the original trialists were contacted about possible unpublished trials.
                     </p>
                  </div>
                  <div id="sec-13" class="subsection">
                     <h3>Selection Criteria</h3>
                     <p id="p-18">We included in the systematic review all randomized controlled trials that compared a dose-dense chemotherapy protocol with
                        a standard schedule of chemotherapy in the neoadjuvant or adjuvant setting in adult women older than 18 years with breast
                        cancer. Trials were included regardless of publication status and language. Two trials in a foreign language were assessed
                        by a native speaker (neither was included in the meta-analysis). We defined two types of trials: Trials that evaluated similar
                        doses of agents in both treatment arms but with condensed schedule in one arm, which we designated conserved dose-dense chemotherapy
                        trials, and trials that compared a condensed schedule with a standard one but used different agents or doses in the two arms
                        were designated modified dose-dense chemotherapy trials. Trials in which overall survival was the primary outcome measure
                        but was not reported were included if all other inclusion criteria were met. Authors of these trials were contacted and asked
                        to provide data for the primary outcome measure if those data have been collected.
                     </p>
                     <p id="p-19">We excluded trials that assessed dose-dense chemotherapy in malignancies other than breast cancer or that evaluated dose-dense
                        chemotherapy combined with radiotherapy, trials in which the definition of dose-dense chemotherapy differed from the original
                        definition (<a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>), trials that included high-dose chemotherapy arms with peripheral stem cell support, and randomized controlled phase II
                        trials that evaluated toxicity only.
                     </p>
                     <p id="p-20">Two authors (LB and IBA) independently inspected each reference title identified by the search and applied the inclusion criteria.
                        For possibly relevant articles and in cases of disagreement between the two reviewers, the full article was obtained and inspected
                        independently by the two reviewers.
                     </p>
                  </div>
                  <div id="sec-14" class="subsection">
                     <h3>Data Extraction and Quality Assessment</h3>
                     <p id="p-21">Trials that fulfilled the systematic review inclusion criteria were assessed for methodological quality by two authors (LB
                        and IBA). Information about randomization and allocation concealment, sample size, exclusions after randomization, and the
                        length of follow-up were recorded as is considered acceptable for Cochrane reviews (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>). The same two authors independently extracted the data from publications of included trials. The data extraction was discussed,
                        decisions were documented, and, if necessary, the authors of the trials were contacted for clarification. Authors of included
                        trials were contacted for all data relevant to the primary and secondary outcomes of this study and quality variables.
                     </p>
                  </div>
                  <div id="sec-15" class="subsection">
                     <h3>Outcome Measures</h3>
                     <p id="p-22">The primary outcome was overall survival, which was defined as time from randomization to death. Secondary outcomes were disease-free
                        survival (defined as the time from randomization to earliest occurrence of relapse or death from any cause), event-free survival
                        (defined as the length of time from the end of treatment to the earliest occurrence of a severe side effect of treatment,
                        cancer recurrence or progression, or death from treatment side effects or from the cancer itself) (<a href="http://www.nature.com/nrc/journal/v3/n7/glossary/nrc1125_glossary.html">www.nature.com/nrc/journal/v3/n7/glossary/nrc1125_glossary.html</a>), and toxicity (defined as grade 3 or 4 hematological and nonhematological adverse events). For the analysis of toxicity,
                        we calculated the mean number of events per chemotherapy cycle by summing all events reported and dividing by the number of
                        cycles delivered in each trial.
                     </p>
                  </div>
                  <div id="sec-16" class="subsection">
                     <h3>Statistical Analysis</h3>
                     <p id="p-23">Hazard ratios (HRs) and variances for time to event outcomes were estimated as described by Parmar et al. (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>) and pooled according to the inverse of variance method with the use of Review Manager software (version 4.2 for Windows;
                        The Cochrane Collaboration, Oxford, UK). A hazard ratio less than 1 favored dose-dense chemotherapy. Pooled relative risks
                        (RRs) and 95% confidence intervals (CIs) for dichotomous data were estimated using the Mantel–Haenszel method (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>). We assessed heterogeneity of the trials’ results by inspecting graphical presentations and by calculating a χ<sup>2</sup> test of heterogeneity and the <em>I</em><sup>2</sup> statistic of inconsistency. We also report the <em>Z</em> statistic for the overall effect (Review Manager). Statistically significant heterogeneity was defined as a χ<sup>2</sup> <em>P</em> value less than .1 or an <em>I</em><sup>2</sup> statistic greater than 50% (<a href="http://www.nature.com/nrc/journal/v3/n7/glossary/nrc1125_glossary.html">www.nature.com/nrc/journal/v3/n7/glossary/nrc1125_glossary.html</a>). We used a fixed-effect model to pool relative risks for toxicity except in the event of statistically significant heterogeneity,
                        in which case a random-effects model was used (ie, the inverse of variance method and the DerSimonian and Laird method) (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>).
                     </p>
                     <p id="p-24">Subgroup analyses were performed to assess potential contributions to the main outcomes. A funnel plot estimating the precision
                        of trials (plots of logarithm of the hazard ratio for efficacy against the sample size) was examined for asymmetry to estimate
                        publication bias. Publication bias was also estimated by the formal Begg–Mazumdar rank correlation test and the Egger test
                        (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>,<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>).
                     </p>
                     <p id="p-25">Sensitivity analyses were performed to assess the robustness of the findings to different aspects of the trials methodology,
                        including allocation concealment (adequate or unclear), exclusions after randomization (reported or not reported), sample
                        size (≤100 vs &gt;100 patients; cutoff was adopted from routine studies in which fewer than 100 patients is considered a “small”
                        study), and length of follow-up. All statistical tests were two-sided. <em>P</em> values less than 0.5 were considered statistically significant.
                     </p>
                  </div>
               </div>
               <div class="section results" id="sec-17">
                  <div class="section-nav"><a href="#sec-11" title="Methods" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-22" title="Discussion" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Results</h2>
                  <p id="p-26">We identified 4869 potentially relevant articles in the primary literature search (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1</a>), of which 11 were randomized phase III trials that met the inclusion criteria and were divided into two groups based on
                     the trial methodology. The first group—the conserved dose-dense chemotherapy trials—included three trials (<a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a>), and the second group—the modified dose-dense chemotherapy trials—included seven trials (<a id="xref-table-wrap-2-1" class="xref-table" href="#T2">Table 2</a>). The PREPARE trial (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>) was included in the systematic review but not in the meta-analysis because no survival outcomes were provided. Chemotherapy
                     protocols of the included trials are listed in <a id="xref-table-wrap-3-1" class="xref-table" href="#T3">Table 3</a>.
                  </p>
                  <div class="table pos-float" id="T1">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="1845/T1.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1845/T1.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label">Table 1</span> 
                        <p id="p-27" class="first-child">Conserved dose-dense chemotherapy trials<sup>*</sup></p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <div class="table pos-float" id="T2">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="1845/T2.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1845/T2.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label">Table 2</span> 
                        <p id="p-33" class="first-child">Modified dose-dense chemotherapy trials<sup>*</sup></p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <div class="table pos-float" id="T3">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="1845/T3.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1845/T3.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label">Table 3</span> 
                        <p id="p-41" class="first-child"> Trials chemotherapy protocols<sup>*</sup></p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <div id="F1" class="fig pos-float  odd">
                     <div class="fig-inline"><a href="1845/F1.expansion.html"><img alt="Figure 1" src="1845/F1.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="1845/F1.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="1845/F1.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services">
                              <li class="ppt-link"><a href="/powerpoint/102/24/1845/F1">Download as PowerPoint Slide</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label">Figure 1</span> 
                        <p id="p-43" class="first-child">Randomized controlled trials search and selection. pCR = pathological complete response; RFS = relapse-free survival.</p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  <div id="sec-18" class="subsection">
                     <h3>Meta-analysis of Conserved Dose-Dense Chemotherapy Trials</h3>
                     <p id="p-44">A total of 3337 patients were randomly assigned in the three trials that we classified as conserved dose-dense chemotherapy
                        trials (<a id="xref-ref-6-4" class="xref-bibr" href="#ref-6">6</a>–<a id="xref-ref-8-4" class="xref-bibr" href="#ref-8">8</a>). In a meta-analysis of these three trials, patients in the dose-dense chemotherapy arms had better overall survival than
                        patients in the conventional chemotherapy arms (HR of death = 0.84; 95% CI = 0.72 to 0.98, <em>P</em> = .03), and there was no heterogeneity among these trials with respect to overall survival (<em>I</em><sup>2</sup> = 0%) (<a id="xref-fig-2-1" class="xref-fig" href="#F2">Figure 2</a>). Dose-dense chemotherapy had a similar benefit with respect to disease-free survival (HR of relapse or death = 0.83; 95%
                        CI = 0.73 to 0.94, <em>P</em> = .005), with no heterogeneity (<em>I</em><sup>2</sup> = 0%) (<a id="xref-fig-3-1" class="xref-fig" href="#F3">Figure 3</a>). In a sensitivity analysis based on estrogen and progesterone receptor status using data from the two trials that examined
                        disease-free survival (<a id="xref-ref-6-5" class="xref-bibr" href="#ref-6">6</a>,<a id="xref-ref-7-5" class="xref-bibr" href="#ref-7">7</a>), dose-dense chemotherapy had a statistically significant benefit with respect to disease-free survival only in receptor-negative
                        patients (HR of relapse or death = 0.71; 95% CI = 0.56 to 0.89; <em>I</em><sup>2</sup> = 0%) (<a id="xref-fig-4-1" class="xref-fig" href="#F4">Figure 4, A and B</a>).
                     </p>
                     <div id="F2" class="fig pos-float  odd">
                        <div class="fig-inline"><a href="1845/F2.expansion.html"><img alt="Figure 2" src="1845/F2.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1845/F2.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1845/F2.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/102/24/1845/F2">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 2</span> 
                           <p id="p-45" class="first-child">Forest plot of hazard ratios (HRs) comparing overall survival for patients who received dose-dense chemotherapy vs those who
                              received conventional chemotherapy in the conserved dose-dense chemotherapy trials, in the modified dose-dense chemotherapy
                              trials, and for all trials combined. Hazard ratios for each trial are represented by the <strong>squares</strong>, the size of the square represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represent the estimated overall effect based on the meta-analysis fixed effect of all trials.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <div id="F3" class="fig pos-float  odd">
                        <div class="fig-inline"><a href="1845/F3.expansion.html"><img alt="Figure 3" src="1845/F3.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1845/F3.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1845/F3.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/102/24/1845/F3">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 3</span> 
                           <p id="p-46" class="first-child">Forest plot of hazard ratios (HRs) comparing disease-free survival for patients who received dose-dense chemotherapy vs those
                              who received conventional chemotherapy in the conserved dose-dense chemotherapy trials, in the modified dose-dense chemotherapy
                              trials, and for all trials combined. Hazard ratios for each trial are represented by the <strong>squares</strong>, the size of the square represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represents the estimated overall effect based on the meta-analysis fixed effect of all trials. ‡EC then T (dose-dense arm)
                              vs AC then T. §EC then T (dose-dense arm) vs CEF.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <div id="F4" class="fig pos-float  odd">
                        <div class="fig-inline"><a href="1845/F4.expansion.html"><img alt="Figure 4" src="1845/F4.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1845/F4.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1845/F4.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/102/24/1845/F4">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 4</span> 
                           <p id="p-47" class="first-child">Forest plot of hazard ratios (HRs) comparing disease-free survival for estrogen receptor–positive and estrogen receptor–negative
                              patients who received dose-dense chemotherapy vs those who received conventional chemotherapy in the conserved dose-dense
                              chemotherapy trials. <strong>A)</strong> Estrogen receptor–positive patients. <strong>B)</strong> Estrogen receptor–negative patients. Hazard ratios for each trial are represented by the <strong>squares</strong>, the size of the square represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represents the estimated overall effect based on the meta-analysis fixed effect of all trials.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                  </div>
                  <div id="sec-19" class="subsection">
                     <h3>Meta-analysis of Modified Dose-Dense Chemotherapy Trials</h3>
                     <p id="p-48">A total of 8652 patients were randomly assigned to seven trials classified as modified dose-dense chemotherapy trials (<a id="xref-ref-11-3" class="xref-bibr" href="#ref-11">11</a>–<a id="xref-ref-16-3" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-23-4" class="xref-bibr" href="#ref-23">23</a>) that evaluated efficacy and toxicity of dose-dense chemotherapy in the adjuvant and neoadjuvant settings. In a meta-analysis
                        of six of these trials (<a id="xref-ref-11-4" class="xref-bibr" href="#ref-11">11</a>–<a id="xref-ref-16-4" class="xref-bibr" href="#ref-16">16</a>), patients in the dose-dense chemotherapy arms had statistically significantly better overall survival than patients in the
                        conventional chemotherapy arms (HR of death = 0.85; 95% CI = 0.75 to 0.96); heterogeneity in overall survival among the trials
                        was low (<em>I</em><sup>2</sup> = 15.5%) (<a id="xref-fig-2-2" class="xref-fig" href="#F2">Figure 2</a>). Dose-dense chemotherapy had a similar benefit with respect to disease-free survival in these six trials (HR of relapse
                        or death = 0.81; 95% CI = 0.73 to 0.88) although the heterogeneity was high (<em>I</em><sup>2</sup> = 53.9%) (<a id="xref-fig-3-2" class="xref-fig" href="#F3">Figure 3</a>). An analysis by receptor status was not performed because of the lack of these data. In the MA21 trial (<a id="xref-ref-23-5" class="xref-bibr" href="#ref-23">23</a>), relapse-free survival did not differ between the treatment arms in the estrogen receptor–positive population.
                     </p>
                  </div>
                  <div id="sec-20" class="subsection">
                     <h3>Meta-analysis of Efficacy for All Dose-Dense Chemotherapy Trials</h3>
                     <p id="p-49">A meta-analysis of all dose-dense chemotherapy trials (<a id="xref-ref-6-6" class="xref-bibr" href="#ref-6">6</a>–<a id="xref-ref-8-5" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-11-5" class="xref-bibr" href="#ref-11">11</a>–<a id="xref-ref-16-5" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-23-6" class="xref-bibr" href="#ref-23">23</a>) revealed that patients who received dose-dense chemotherapy had statistically significantly better overall survival (HR
                        of death = 0.85; 95% CI = 0.77 to 0.93) (<a id="xref-fig-2-3" class="xref-fig" href="#F2">Figure 2</a>) and disease-free survival (HR of relapse or death = 0.81; 95% CI = 0.75 to 0.88) (<a id="xref-fig-3-3" class="xref-fig" href="#F3">Figure 3</a>) compared with patients who received conventional chemotherapy. No heterogeneity was observed among the trials for overall
                        survival (<em>I</em><sup>2</sup> = 0%), and low heterogeneity was observed for disease-free survival (<em>I</em><sup>2</sup> = 37%).
                     </p>
                     <p id="p-50">A funnel plot of the primary outcome revealed slight asymmetry, which may indicate a small study effect (ie, publication bias)
                        (<a id="xref-fig-5-1" class="xref-fig" href="#F5">Figure 5</a>). However, neither the Egger linear regression test (<em>P</em> = .066) nor the Begg–Mazumdar rank correlation test (<em>P</em> = .14) showed a statistically significant association between the study effects and the study size.
                     </p>
                     <div id="F5" class="fig pos-float  odd">
                        <div class="fig-inline"><a href="1845/F5.expansion.html"><img alt="Figure 5" src="1845/F5.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1845/F5.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1845/F5.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/102/24/1845/F5">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 5</span> 
                           <p id="p-51" class="first-child">Funnel plot of overall survival in all dose-dense chemotherapy trials for the visual detection of systematic publication bias
                              and small study effect. Each <strong>circle</strong> represents treatment effect expressed as the logarithm of the hazard ratio of overall survival in each trial plotted against
                              standard error as a measure of study size. The <strong>diamond</strong> and the <strong>vertical line</strong> represent the pooled estimate from the meta-analysis.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                  </div>
                  <div id="sec-21" class="subsection">
                     <h3>Meta-analysis of Adverse Events</h3>
                     <p id="p-52">In the three conserved dose-dense chemotherapy trials, there was no difference in the number of grade 3 or 4 adverse events
                        between the dose-dense and conventional chemotherapy arms (RR = 1.13; 95% CI = 0.91 to 1.39, <em>I</em><sup>2</sup> = 0%) (<a id="xref-fig-6-1" class="xref-fig" href="#F6">Figure 6, A</a>). Delivery of dose-dense chemotherapy requires the use of growth factor support, which may prevent grade 3 and 4 neutropenia.
                        We therefore performed an analysis that excluded bone marrow–related toxicity. The number of grade 3 or 4 nonhematological
                        adverse events was higher in the dose-dense chemotherapy arm than in the conventional chemotherapy arm (RR = 1.32; 95% CI
                        = 1.04 to 1.66, <em>I</em><sup>2</sup> = 0%) (<a id="xref-fig-6-2" class="xref-fig" href="#F6">Figure 6, B</a>). We obtained nonconclusive results regarding adverse events in the modified dose-dense chemotherapy trials because of high
                        heterogeneity (<em>I</em><sup>2</sup> = 95.8%). Thus, we used a random-effect model, which showed non-statistically significant higher toxicity in the dose-dense
                        chemotherapy arm compared with the conventional chemotherapy arm (RR = 1.36; 95% CI = 0.87 to 2.13; <em>P</em> = .18).
                     </p>
                     <div id="F6" class="fig pos-float  odd">
                        <div class="fig-inline"><a href="1845/F6.expansion.html"><img alt="Figure 6" src="1845/F6.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1845/F6.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1845/F6.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/102/24/1845/F6">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 6</span> 
                           <p id="p-53" class="first-child">Forest plots of relative risks (RRs) of adverse events for patients who received dose-dense chemotherapy vs those who received
                              conventional chemotherapy in the conserved dose-dense chemotherapy trials. <strong>A</strong>) All grade 3–4 adverse events. <strong>B</strong>) Grade 3–4 adverse events except leukopenia. Relative risks for each trial are represented by the <strong>squares</strong>, the size of the square represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represents the estimated overall effect based on the meta-analysis fixed effect of all trials.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                  </div>
               </div>
               <div class="section discussion" id="sec-22">
                  <div class="section-nav"><a href="#sec-17" title="Results" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-23" title="Funding" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Discussion</h2>
                  <p id="p-54">This systematic review and meta-analysis shows that dose-dense chemotherapy for the treatment of women with high-risk breast
                     cancer improves both disease-free and overall survival compared with conventional chemotherapy. The dose-dense chemotherapy
                     approach resulted in better overall survival and better disease-free survival in trials that evaluated similar doses of agents
                     in both treatment arms but with a condensed schedule in one arm as well as in trials that compared a condensed schedule with
                     standard one but used different agents or doses in the two arms. The results for all trials combined were statistically significant,
                     with no statistical heterogeneity among the trials.
                  </p>
                  <p id="p-55">The other important finding of this systematic review is the paucity of randomized controlled trials with an adequate study
                     design, that is, trials that evaluate the same agents and doses in the conventional arm as in the investigational arm. Most
                     of the trials included in the meta-analysis did not preserve this last characteristic, which is why we classified the trials
                     according to their design.
                  </p>
                  <p id="p-56">Two recent trials have addressed the dose-dense chemotherapy approach. The recently published Canadian MA21 trial (<a id="xref-ref-23-7" class="xref-bibr" href="#ref-23">23</a>), which included three treatment arms that were anthracycline based, may provide key answers about the efficacy of the dose-dense
                     approach with and without the use of taxane therapy. The PREPARE trial (<a id="xref-ref-24-4" class="xref-bibr" href="#ref-24">24</a>), which evaluated the effect of preoperative dose-dense and dose-intensified chemotherapy with anthracycline and taxane with
                     or without darbepoetin alfa in breast cancer patients, was not included in the meta-analysis due to lack of outcome data.
                  </p>
                  <p id="p-57">Our meta-analysis of the efficacy of dose-dense chemotherapy according to hormone receptor status revealed that hormone receptor–positive
                     patients did not benefit from dose-dense chemotherapy. This result was based on data from the conserved dose-dense chemotherapy
                     trials; data from the modified dose-dense chemotherapy trials were not available. Nevertheless, data from the MA21 trial further
                     support this finding. In the MA21 trial, relapse-free survival did not differ between the treatment arms in estrogen receptor–positive
                     patients. Restricting the use of dose-dense chemotherapy to hormone receptor–negative patients may be justified, both in terms
                     of the costs and the potential adverse events (<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>).
                  </p>
                  <p id="p-58">We also found that there was no increase in overall treatment-related adverse events associated with the dose-dense approach.
                     Because a dose-dense chemotherapy schedule requires granulocyte colony-stimulating factor support, we performed an analysis
                     of adverse events that excluded bone marrow–related events. In the conserved dose-dense chemotherapy trials, the number of
                     nonhematological adverse events for the dose-dense chemotherapy arms was higher compared with that in the conventional chemotherapy
                     arm. However, because of high heterogeneity among the modified dose-dense chemotherapy trials, the increase in adverse events
                     for dose-dense vs conventional chemotherapy was not statistically significant.
                  </p>
                  <p id="p-59">The dose-dense chemotherapy approach uses prophylactic growth factor support to facilitate the safe delivery of dose-dense
                     chemotherapy (<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>,<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>). The economic burden of this issue, as well as possible unrecognized growth factor–related toxicities, such as pulmonary
                     toxicity, should be considered (<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>).
                  </p>
                  <p id="p-60">Several limitations of this analysis must be acknowledged. First, only three randomized controlled trials used the same agents
                     and doses in the conventional chemotherapy arm as in the investigational (ie, dose-dense chemotherapy) arm. The fact that
                     most of the included trials did not evaluate the same agents and dose in both arms resulted in major statistical heterogeneity
                     among the trials. Second, the slight asymmetry of the funnel plot of the primary outcome suggests small study effects. Although
                     results of the Egger and Begg–Mazumdar tests did not support the possibility of publication bias, the small number of included
                     trials makes it difficult to distinguish a chance finding from true asymmetry. Also, the small number of included trials makes
                     the outcomes more likely to have been influenced by a potential publication bias. We attempted to avoid such bias by searching
                     for and including in our meta-analysis conference proceedings, databases of ongoing trials, and unpublished data.
                  </p>
                  <p id="p-61">Studies are needed to better define the patient population that will benefit the most from dose-dense chemotherapy. The concept
                     of metronomic chemotherapy as evaluated, for example, by the Southwest Oncology Group (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>) is a variation of the dose-dense strategy whereby chemotherapy is administered as relatively low and minimally toxic doses
                     at frequent and regular intervals (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>). Assessing the efficacy and feasibility of this milder chemotherapeutic approach might identify ways to integrate biological
                     performance with the best treatment. This analysis indicates that dose-dense chemotherapy has a clear benefit for patients
                     with hormone receptor–negative breast cancer. The lack of obvious benefit in patients with hormone receptor–positive breast
                     cancer shown by this analysis indicates the need for further prospective randomized trials of the classical conserved design
                     in this patient population.
                  </p>
               </div>
               <div class="section" id="sec-23">
                  <div class="section-nav"><a href="#sec-22" title="Discussion" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Funding</h2>
                  <p id="p-62">The authors received no external funding for this study.</p>
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#sec-23" title="Funding" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Footnotes</h2>
                  <ul>
                     <li class="fn" id="fn-14">
                        <p id="p-63">L. Bonilla, I. Ben-Aharon, L. Leibovici, and S. M. Stemmer contributed equally to this study. The authors take full responsibility
                           for the design of the study; the collection, analysis, and interpretation of the data; the writing of the manuscript; and
                           the decision to submit the manuscript for publication.
                        </p>
                     </li>
                  </ul>
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">© The Author 2010. Published by Oxford University Press.</li>
               </ul>
               <div class="license" id="license-1">
                  <p id="p-1">This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence
                     (<a href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</a>) which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not
                     altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
                  </p>
               </div>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text"
                           id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.1"
                             data-doi="10.1016/S0140-6736(05)66544-0">
                           <div class="cit-metadata"><cite><span class="cit-auth cit-collab">Early Breast Cancer Trialists Collaborative Group (EBCTCG)</span>. <span class="cit-article-title">Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the
                                    randomized trials</span>. <abbr class="cit-jnl-abbrev">Lancet.</abbr> <span class="cit-pub-date">2005</span>;<span class="cit-vol">365</span>(<span class="cit-issue">9472</span>):<span class="cit-fpage">1687</span>-<span class="cit-lpage">1717</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(05)66544-0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15894097&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000229082300022&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text"
                           id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.2">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hryniuk</span>  <span class="cit-name-given-names">WM</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Average relative dose intensity and the impact on design of clinical trials</span>. <abbr class="cit-jnl-abbrev">Semin Oncol</abbr> <span class="cit-pub-date">1987</span>;<span class="cit-vol">14</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">65</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=3823917&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1987G445500005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Average%20relative%20dose%20intensity%20and%20the%20impact%20on%20design%20of%20clinical%20trials&amp;author=WM%20Hryniuk&amp;publication_year=1987&amp;journal=Semin%20Oncol&amp;volume=14&amp;issue=1&amp;pages=65">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text"
                           id="ref-3">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.3"
                             data-doi="10.1023/A:1008295432012">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Biganzoli</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Piccart</span>  <span class="cit-name-given-names">MJ</span></span></li>
                              </ol><cite>. <span class="cit-article-title">The bigger the better? Or what we know and what we still need to learn about anthracycline dose per course, dose density and
                                    cumulative dose in the treatment of breast cancer</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr> <span class="cit-pub-date">1997</span>;<span class="cit-vol">8</span>(<span class="cit-issue">12</span>):<span class="cit-fpage">1177</span>-<span class="cit-lpage">1182</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=annonc&amp;resid=8/12/1177"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text"
                           id="ref-4">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.4">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hudis</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Seidman</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Baselga</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and
                                    efficacy</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1999</span>;<span class="cit-vol">17</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">93</span>-<span class="cit-lpage">100</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=17/1/93"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text"
                           id="ref-5">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.5">
                           <div class="cit-metadata"><cite><span class="cit-article-title">Norton La: A Gompertzian model of human breast cancer growth</span>. <abbr class="cit-jnl-abbrev">Cancer Res</abbr> <span class="cit-pub-date">1988</span>;<span class="cit-vol">48</span>(<span class="cit-issue">24, pt 1</span>):<span class="cit-fpage">7067</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=48/24_Part_1/7067"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text"
                           id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.6"
                             data-doi="10.1200/JCO.2003.09.081">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Citron</span>  <span class="cit-name-given-names">ML</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berry</span>  <span class="cit-name-given-names">DA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cirrincione</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as
                                    postoperative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741. Cancer and
                                    Leukemia Group B Trial 9741</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2003</span>;<span class="cit-vol">21</span>(<span class="cit-issue">8</span>):<span class="cit-fpage">1431</span>-<span class="cit-lpage">1439</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=21/8/1431"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">7.</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text"
                           id="ref-7">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.7"
                             data-doi="10.1093/jnci/dji398">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Venturini</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Del Mastro</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Aitini</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">2005</span>;<span class="cit-vol">97</span>(<span class="cit-issue">23</span>):<span class="cit-fpage">1724</span>-<span class="cit-lpage">1733</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=97/23/1724"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text"
                           id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.8"
                             data-doi="10.1093/annonc/mdg069">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Baldini</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Gardin</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Giannessi</span>  <span class="cit-name-given-names">PG</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil:
                                    a randomized phase III trial in locally advanced breast cancer</span>. <abbr class="cit-jnl-abbrev">Ann Oncol</abbr> <span class="cit-pub-date">2003</span>;<span class="cit-vol">14</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">227</span>-<span class="cit-lpage">232</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=14/2/227"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text"
                           id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.9">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Untch</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thomssen</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Steffen</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Five year results of a randomized multicenter dose intense (DI-EC) study with epirubicin (E) and cyclophosphamide (C) in high
                                    risk breast cancer patients: a treatment of short duration with comparable efficacy to conventional chemotherapy</span>. <abbr class="cit-jnl-abbrev">Breast Cancer Res Treat</abbr> <span class="cit-pub-date">2002</span>;<span class="cit-vol">76</span> <span class="cit-supplement">suppl 1</span>:<span class="cit-fpage">S158</span>. <span class="cit-comment">Abstract 641</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Five%20year%20results%20of%20a%20randomized%20multicenter%20dose%20intense%20%28DI-EC%29%20study%20with%20epirubicin%20%28E%29%20and%20cyclophosphamide%20%28C%29%20in%20high%20risk%20breast%20cancer%20patients%3A%20a%20treatment%20of%20short%20duration%20with%20comparable%20efficacy%20to%20conventional%20chemotherapy&amp;author=M%20Untch&amp;author=C%20Thomssen&amp;author=K%20Steffen&amp;publication_year=2002&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=76&amp;pages=S158">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">10.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-102.24.1845.10">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Seidman</span>  <span class="cit-name-given-names">AD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hudis</span>  <span class="cit-name-given-names">CA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Albanel</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">1998</span>;<span class="cit-vol">16</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">3353</span>-<span class="cit-lpage">3361</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=16/10/3353"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-3" title="View reference 11. in text"
                           id="ref-11">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.11"
                             data-doi="10.1200/JCO.2006.07.0847">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Linden</span>  <span class="cit-name-given-names">HM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Haskell</span>  <span class="cit-name-given-names">CM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Green</span>  <span class="cit-name-given-names">SJ</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis
                                    from INT-0137 (S9313)</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2007</span>;<span class="cit-vol">25</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">656</span>-<span class="cit-lpage">661</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=25/6/656"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">12.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-102.24.1845.12">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Möbus</span>  <span class="cit-name-given-names">VJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Untch</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Du Bois</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Dose-dense sequential chemotherapy with epirubicin(E), paclitaxel (T) and cyclophosphamide (C) (ETC) is superior to conventional
                                    dosed chemotherapy in high-risk breast cancer patients (≥ 4 +LN). First results of an AGO-trial</span>. <abbr class="cit-jnl-abbrev">Proc Am Soc Clin Oncol</abbr> <span class="cit-pub-date">2004</span>;<span class="cit-vol">22</span>(<span class="cit-issue">suppl July 15</span>):<span class="cit-fpage">S14</span>. <span class="cit-comment">Abstract 513</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Dose-dense%20sequential%20chemotherapy%20with%20epirubicin%28E%29%2C%20paclitaxel%20%28T%29%20and%20cyclophosphamide%20%28C%29%20%28ETC%29%20is%20superior%20to%20conventional%20dosed%20chemotherapy%20in%20high-risk%20breast%20cancer%20patients%20%28%E2%89%A5%204%20%2BLN%29.%20First%20results%20of%20an%20AGO-trial&amp;author=VJ%20M%C3%B6bus&amp;author=M%20Untch&amp;author=A%20Du%20Bois&amp;publication_year=2004&amp;journal=Proc%20Am%20Soc%20Clin%20Oncol&amp;volume=22&amp;issue=suppl%20July%2015&amp;pages=S14">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">13.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-102.24.1845.13"
                             data-doi="10.1200/JCO.2003.05.135">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Therasse</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mauriac</span>  <span class="cit-name-given-names">L</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Welnicka-Jaskiewicz</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with dose intensified
                                    epirubicin and cyclophosphamide plus filgrastim as neoadjuvant treatment in locally advanced breast cancer. An EORTC-NCIC-SAKK
                                    multicenter study</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2003</span>;<span class="cit-vol">21</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">843</span>-<span class="cit-lpage">850</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=21/5/843"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">14.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-102.24.1845.14"
                             data-doi="10.1200/JCO.2005.05.078">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Von Minckwitz</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Raab</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Caputo</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days
                                    as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2005</span>;<span class="cit-vol">23</span>(<span class="cit-issue">12</span>):<span class="cit-fpage">2676</span>-<span class="cit-lpage">2685</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=23/12/2676"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">15.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-102.24.1845.15"
                             data-doi="10.1038/sj.bjc.6603085">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kümmel</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Krocker</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kohls</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer</span>. <abbr class="cit-jnl-abbrev">Br J Cancer</abbr> <span class="cit-pub-date">2006</span>;<span class="cit-vol">94</span>(<span class="cit-issue">9</span>):<span class="cit-fpage">1237</span>-<span class="cit-lpage">1244</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/sj.bjc.6603085&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16622463&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000237238700006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Randomised%20trial%3A%20survival%20benefit%20and%20safety%20of%20adjuvant%20dose-dense%20chemotherapy%20for%20node-positive%20breast%20cancer&amp;author=S%20K%C3%BCmmel&amp;author=J%20Krocker&amp;author=A%20Kohls&amp;publication_year=2006&amp;journal=Br%20J%20Cancer&amp;volume=94&amp;issue=9&amp;pages=1237-1244">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-3" title="View reference 16. in text"
                           id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.16"
                             data-doi="10.1200/JCO.2008.20.3133">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Untch</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Möbus</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kuhn</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2009</span>;<span class="cit-vol">27</span>(<span class="cit-issue">18</span>):<span class="cit-fpage">2938</span>-<span class="cit-lpage">2945</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=27/18/2938"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text"
                           id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.17"
                             data-doi="10.1016/0197-2456(86)90046-2">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">DerSimonian</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Laird</span>  <span class="cit-name-given-names">N</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Meta-analysis in clinical trials</span>. <abbr class="cit-jnl-abbrev">Control Clin Trials</abbr> <span class="cit-pub-date">1986</span>;<span class="cit-vol">7</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">177</span>-<span class="cit-lpage">188</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0197-2456(86)90046-2&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=3802833&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1986F013900001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Meta-analysis%20in%20clinical%20trials&amp;author=R%20DerSimonian&amp;author=N%20Laird&amp;publication_year=1986&amp;journal=Control%20Clin%20Trials&amp;volume=7&amp;issue=3&amp;pages=177-188">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text"
                           id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.18"
                             data-doi="10.1136/bmj.315.7109.629">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Egger</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">GD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schneider</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Minder</span>  <span class="cit-name-given-names">C</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Bias in meta-analysis detected by a simple graphical test</span>. <abbr class="cit-jnl-abbrev">BMJ</abbr> <span class="cit-pub-date">1997</span>;<span class="cit-vol">315</span>(<span class="cit-issue">7109</span>):<span class="cit-fpage">629</span>-<span class="cit-lpage">634</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=bmj&amp;resid=315/7109/629"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text"
                           id="ref-19">↵</a><div class="cit ref-cit ref-book" id="cit-102.24.1845.19">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Higgins</span>  <span class="cit-name-given-names">JPT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Green</span>  <span class="cit-name-given-names">S</span></span></li>
                              </ol><cite>. <span class="cit-source">Cochrane Handbook for Systematic Reviews of Interventions Version 5.0</span>. <span class="cit-publ-name">The Cochrane Collaboration</span>; <span class="cit-pub-date">2008</span>. <span class="cit-comment"><a href="http://www.cochrane-handbook.org">www.cochrane-handbook.org</a>. Accessed September 30, 2008</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text"
                           id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.20"
                             data-doi="10.1002/(SICI)1097-0258(19981230)17:24&lt;2815::AID-SIM110&gt;3.0.CO;2-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Parmar</span>  <span class="cit-name-given-names">MK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Torri</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stewart</span>  <span class="cit-name-given-names">L</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints</span>. <abbr class="cit-jnl-abbrev">Stat Med</abbr> <span class="cit-pub-date">1998</span>;<span class="cit-vol">17</span>:<span class="cit-fpage">2815</span>-<span class="cit-lpage">2834</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/(SICI)1097-0258(19981230)17:24%3C2815::AID-SIM110%3E3.0.CO;2-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9921604&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000077527600003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Extracting%20summary%20statistics%20to%20perform%20meta-analyses%20of%20the%20published%20literature%20for%20survival%20endpoints&amp;author=MK%20Parmar&amp;author=V%20Torri&amp;author=L%20Stewart&amp;publication_year=1998&amp;journal=Stat%20Med&amp;volume=17&amp;pages=2815-2834">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text"
                           id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.21">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mantel</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Haenszel</span>  <span class="cit-name-given-names">W</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Statistical aspects of the analysis of data from retrospective studies of disease</span>. <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr> <span class="cit-pub-date">1959</span>;<span class="cit-vol">22</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">719</span>-<span class="cit-lpage">748</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=13655060&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1959WD28900006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Statistical%20aspects%20of%20the%20analysis%20of%20data%20from%20retrospective%20studies%20of%20disease&amp;author=N%20Mantel&amp;author=W%20Haenszel&amp;publication_year=1959&amp;journal=J%20Natl%20Cancer%20Inst&amp;volume=22&amp;issue=4&amp;pages=719-748">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text"
                           id="ref-22">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.22"
                             data-doi="10.2307/2533446">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Begg</span>  <span class="cit-name-given-names">CB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mazumdar</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Operating characteristics of a rank correlation test for publication bias</span>. <abbr class="cit-jnl-abbrev">Biometrics</abbr> <span class="cit-pub-date">1994</span>;<span class="cit-vol">50</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">1088</span>-<span class="cit-lpage">1101</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2307/2533446&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7786990&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994QP05000016&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Operating%20characteristics%20of%20a%20rank%20correlation%20test%20for%20publication%20bias&amp;author=CB%20Begg&amp;author=M%20Mazumdar&amp;publication_year=1994&amp;journal=Biometrics&amp;volume=50&amp;issue=4&amp;pages=1088-1101">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-4" title="View reference 23. in text"
                           id="ref-23">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.23"
                             data-doi="10.1200/JCO.2009.22.1077">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Burnell</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Levine</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Chapman</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Cyclophosphamide, epirubicin, and fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by paclitaxel versus
                                    doxorubicin and cyclophosphamide followed by paclitaxel in node-positive or high-risk node-negative breast cancer</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2010</span>;<span class="cit-vol">28</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">77</span>-<span class="cit-lpage">82</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=28/1/77"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text"
                           id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.24">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Untch</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fasching</span>  <span class="cit-name-given-names">PA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bauerfeind</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">PREPARE trial. A randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin,
                                    paclitaxel and CMF with a standard dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbapoetin alfa in primary
                                    breast cancer: a preplanned interim analysis of efficacy at surgery</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2008</span>;<span class="cit-vol">26</span>(<span class="cit-issue">suppl May 20</span>). <span class="cit-comment">Abstract 517</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=PREPARE%20trial.%20A%20randomized%20phase%20III%20trial%20comparing%20preoperative%2C%20dose-dense%2C%20dose-intensified%20chemotherapy%20with%20epirubicin%2C%20paclitaxel%20and%20CMF%20with%20a%20standard%20dosed%20epirubicin%2Fcyclophosphamide%20followed%20by%20paclitaxel%20%C2%B1%20darbapoetin%20alfa%20in%20primary%20breast%20cancer%3A%20a%20preplanned%20interim%20analysis%20of%20efficacy%20at%20surgery&amp;author=M%20Untch&amp;author=PA%20Fasching&amp;author=I%20Bauerfeind&amp;publication_year=2008&amp;journal=J%20Clin%20Oncol&amp;volume=26&amp;issue=suppl%20May%2020">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">25.</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25. in text"
                           id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.25">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kümmel</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rezai</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kimmig</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Schmid</span>  <span class="cit-name-given-names">P</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Dose-dense chemotherapy for primary breast cancer</span>. <abbr class="cit-jnl-abbrev">Curr Opin Obstet Gynecol</abbr> <span class="cit-pub-date">2007</span>;<span class="cit-vol">19</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">75</span>-<span class="cit-lpage">81</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=17218856&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000243814300014&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Dose-dense%20chemotherapy%20for%20primary%20breast%20cancer&amp;author=S%20K%C3%BCmmel&amp;author=M%20Rezai&amp;author=R%20Kimmig&amp;author=P%20Schmid&amp;publication_year=2007&amp;journal=Curr%20Opin%20Obstet%20Gynecol&amp;volume=19&amp;issue=1&amp;pages=75-81">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">26.</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26. in text"
                           id="ref-26">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.26">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Doorduijn</span>  <span class="cit-name-given-names">JK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buijt</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Van der Holt</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive
                                    non-Hodgkin’s lymphoma</span>. <abbr class="cit-jnl-abbrev">Haematologica</abbr> <span class="cit-pub-date">2004</span>;<span class="cit-vol">89</span>(<span class="cit-issue">9</span>):<span class="cit-fpage">1109</span>-<span class="cit-lpage">1117</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=haematol&amp;resid=89/9/1109"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">27.</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27. in text"
                           id="ref-27">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.27"
                             data-doi="10.1200/JCO.2005.04.3281">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Timmer-Bonte</span>  <span class="cit-name-given-names">JN</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Adang</span>  <span class="cit-name-given-names">EM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Smit</span>  <span class="cit-name-given-names">HJ</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung
                                    cancer</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr> <span class="cit-pub-date">2006</span>;<span class="cit-vol">24</span>(<span class="cit-issue">19</span>):<span class="cit-fpage">2991</span>-<span class="cit-lpage">2997</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=24/19/2991"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">28.</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28. in text"
                           id="ref-28">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.28"
                             data-doi="10.1093/annonc/mdn652">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yerushalmi</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kramer</span>  <span class="cit-name-given-names">MR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rizel</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study</span>. <abbr class="cit-jnl-abbrev">Ann Oncol.</abbr> <span class="cit-pub-date">2009</span>;<span class="cit-vol">20</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">437</span>-<span class="cit-lpage">440</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=20/3/437"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">29.</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29. in text"
                           id="ref-29">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.29">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ellis</span>  <span class="cit-name-given-names">GK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Green</span>  <span class="cit-name-given-names">SJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Russell</span>  <span class="cit-name-given-names">CA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al</span></li>
                              </ol><cite>. <span class="cit-article-title">SWOG 0012, A randomized phase III comparison of standard doxorubicin and cyclophosphamide followed by weekly paclitaxel versus
                                    weekly doxorubicin and daily oral cyclophosphamide plus G-CSF followed by weekly paclitaxel as neoadjuvant therapy for inflammatory
                                    and locally advanced breast cancer</span>. <abbr class="cit-jnl-abbrev">J Clin Oncol.</abbr> <span class="cit-pub-date">2006</span>;<span class="cit-vol">24</span>(<span class="cit-issue">12s</span>) <span class="cit-supplement">suppl 18</span>. <span class="cit-comment">LBA537</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=SWOG%200012%2C%20A%20randomized%20phase%20III%20comparison%20of%20standard%20doxorubicin%20and%20cyclophosphamide%20followed%20by%20weekly%20paclitaxel%20versus%20weekly%20doxorubicin%20and%20daily%20oral%20cyclophosphamide%20plus%20G-CSF%20followed%20by%20weekly%20paclitaxel%20as%20neoadjuvant%20therapy%20for%20inflammatory%20and%20locally%20advanced%20breast%20cancer&amp;author=GK%20Ellis&amp;author=SJ%20Green&amp;author=CA%20Russell&amp;publication_year=2006&amp;journal=J%20Clin%20Oncol.&amp;volume=24&amp;issue=12s">Google Scholar</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label">30.</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30. in text"
                           id="ref-30">↵</a><div class="cit ref-cit ref-journal" id="cit-102.24.1845.30">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">McArthur</span>  <span class="cit-name-given-names">HL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hudis</span>  <span class="cit-name-given-names">CA</span></span></li>
                              </ol><cite>. <span class="cit-article-title">Dose-dense therapy in the treatment of early-stage breast cancer: an overview of the data</span>. <abbr class="cit-jnl-abbrev">Clin Breast Cancer</abbr> <span class="cit-pub-date">2007</span>: <span class="cit-supplement">suppl 1</span>:<span class="cit-fpage">S6</span>-<span class="cit-lpage">S10</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Dose-dense%20therapy%20in%20the%20treatment%20of%20early-stage%20breast%20cancer%3A%20an%20overview%20of%20the%20data&amp;author=HL%20McArthur&amp;author=CA%20Hudis&amp;publication_year=2007&amp;journal=Clin%20Breast%20Cancer&amp;pages=S6-S10">Google Scholar</a></div>
                        </div>
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div>
            <div id="related">
               <h2>Related articles</h2>
               <ul class="related-list">
                  <div class="cit">
                     <div class="cit-metadata"><span class="cit-first-element cit-section">IN THIS ISSUE<span class="cit-sep cit-sep-after-article-section">:</span> </span><span class="cit-title">IN THIS ISSUE </span> <cite><abbr title="Journal of the National Cancer Institute" class="site-title">JNCI J Natl Cancer Inst</abbr> <span class="cit-print-date"><span class="cit-sep cit-sep-before-article-print-date">(</span>2010<span class="cit-sep cit-sep-after-article-print-date">)</span> </span><span class="cit-vol">102 </span><span class="cit-issue"><span class="cit-sep cit-sep-before-article-issue">(</span>24<span class="cit-sep cit-sep-after-article-issue">):</span> </span><span class="cit-pages"><span class="cit-first-page">1813</span> </span><span class="cit-doi"><span class="cit-sep cit-sep-before-article-doi"> doi:</span>10.1093/jnci/djq519 </span><span class="cit-online-date"><span class="cit-sep cit-sep-before-article-online-date">First published online </span>December 14, 2010 </span></cite>  
                     </div>
                     <div class="cit-extra"><span class="accesscheck jnci;102/24/1813 pdf_extract,full,reprint"></span> 
                        <ul class="cit-views">
                           <li class="first-item"><a href="/content/102/24/1813.extract" rel="extract">Extract</a></li>
                           <li><a href="/content/102/24/1813.full" rel="full-text">Full Text (HTML)</a></li>
                           <li class="last-item"><a href="/content/102/24/1813.full.pdf+html" rel="full-text.pdf">Full Text (PDF)</a></li>
                        </ul> <span class="cit-flags"><span class="open-access-note">OPEN ACCESS</span> </span> 
                     </div> 
                  </div>
               </ul>
            </div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/102/24/1835.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/102/24/1855.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/102/24.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (2010) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    102
                                    </span><span class="slug-issue">
                                    (24):
                                    </span><span class="slug-pages">
                                    1845-1854.
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/djq409" class="slug-doi">10.1093/jnci/djq409</span>
                                    </span>
                                 </cite>
                              
                              
                              <span class="slug-metadata-note ahead-of-print">
                                 
                                 First published online
                                 
                                 <span class="slug-ahead-of-print-date">November 23, 2010</span>
                                 </span>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li><span class="creative-commons-article">This article is Open Access<span>OA</span></span></li>
                        <li><span class="ccv cc-version-by-nc/3.0/"></span></li>
                        <li class="abstract-view-link primary"><a href="/content/102/24/1845.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/102/24/1845.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                        <li class="cb-versions">
                           <div><span id="pap-all-versions-label">All Versions of this Article:</span><ol class="version-list">
                                 <li><a href="/content/early/2010/11/23/jnci.djq409">djq409v1</a></li>
                                 <li class="current-li"><span>102/24/1845</span> <span class="current-version">most recent</span></li>
                              </ol>
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=ARTICLES&amp;sortspec=date&amp;submit=Submit">Article</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;102/24/1845" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B102%2F24%2F1845&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/102/24/1845.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=102/24/1845&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/102/24/1845.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3Bdjq409&amp;citation=Bonilla%20et%20al.%20102%20%2824%29:%201845&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B102%2F24%2F1845&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=21098761&amp;link_type=MED_NBRS"
                              class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B102%2F24%2F1845">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B102%2F24%2F1845">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Dose-Dense%20Chemotherapy%20in%20Nonmetastatic%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-analysis%20of%20Randomized%20Controlled%20Trials%3A%20&amp;publicationDate=12%2F15%2F2010&amp;author=Luisa%20Bonilla%2C%20Irit%20Ben-Aharon%2C%20Liat%20Vidal%2C%20Anat%20Gafter-Gvili%2C%20Leonard%20Leibovici%2C%20Salomon%20M.%20Stemmer&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2Fdjq409&amp;volumeNum=102&amp;issueNum=24&amp;startPage=1845&amp;endPage=1854&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/102/24/1845.full?cited-by=yes&amp;legid=jnci;102/24/1845#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/102/24/1845" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/102/24/1845?access_num=/jnci/102/24/1845"
                              rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F102%2F24%2F1845&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/102/24/1845.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ABonilla%20author%3AL.%22"
                              class="cb-art-gs-auth author-link">Articles by  Bonilla, L.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AStemmer%20author%3AS.M.%22"
                              class="cb-art-gs-auth author-link">Articles by  Stemmer, S. M.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/102/24/1845.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=21098761&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Bonilla%20L&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Bonilla, L.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Ben-Aharon%20I&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Ben-Aharon, I.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Vidal%20L&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Vidal, L.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Gafter-Gvili%20A&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Gafter-Gvili, A.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Leibovici%20L&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Leibovici, L.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Stemmer%20SM&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Stemmer, S. M.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="#related">Related articles in this journal</a></li>
                        <li><a href="/content/102/24/1845.full?related-urls=yes&amp;legid=jnci;102/24/1845#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B102%2F24%2F1845&amp;current-view-path=/content/102/24/1845.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/102/24/1845&amp;title=Dose-Dense%20Chemotherapy%20in%20Nonmetastatic%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-analysis%20of%20Randomized%20Controlled%20Trials+--+Bonilla%20et%20al.%20102%20%2824%29%3A%201845+--+jnci&amp;doi=10.1093/jnci/djq409&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/102/24/1845&amp;title=Dose-Dense%20Chemotherapy%20in%20Nonmetastatic%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-analysis%20of%20Randomized%20Controlled%20Trials+--+Bonilla%20et%20al.%20102%20%2824%29%3A%201845+--+jnci&amp;doi=10.1093/jnci/djq409&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/102/24/1845&amp;title=Dose-Dense%20Chemotherapy%20in%20Nonmetastatic%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-analysis%20of%20Randomized%20Controlled%20Trials+--+Bonilla%20et%20al.%20102%20%2824%29%3A%201845+--+jnci&amp;doi=10.1093/jnci/djq409&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/102/24/1845&amp;title=Dose-Dense%20Chemotherapy%20in%20Nonmetastatic%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-analysis%20of%20Randomized%20Controlled%20Trials+--+Bonilla%20et%20al.%20102%20%2824%29%3A%201845+--+jnci&amp;doi=10.1093/jnci/djq409&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/102/24/1845&amp;title=Dose-Dense%20Chemotherapy%20in%20Nonmetastatic%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-analysis%20of%20Randomized%20Controlled%20Trials+--+Bonilla%20et%20al.%20102%20%2824%29%3A%201845+--+jnci&amp;doi=10.1093/jnci/djq409&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/102/24/1845&amp;title=Dose-Dense%20Chemotherapy%20in%20Nonmetastatic%20Breast%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-analysis%20of%20Randomized%20Controlled%20Trials+--+Bonilla%20et%20al.%20102%20%2824%29%3A%201845+--+jnci&amp;doi=10.1093/jnci/djq409&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-11">Methods</a></li>
                        <li><a href="#sec-17">Results</a></li>
                        <li><a href="#sec-22">Discussion</a></li>
                        <li><a href="#sec-23">Funding</a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/102/24/1845.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/102/24/1845.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>